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Background: Seventy-five million people are estimated to be hypertensive in sub-Saharan Africa. This translates in
high morbidity and mortality, as hypertension is now considered to be the number one single risk factor for death
worldwide. Accurate data from countries lacking national disease surveillance is needed to guide future
evidence-driven health policies. The authors aimed to estimate the prevalence, awareness, management and
control of hypertension and associated factors in an adult population of Angola.
Methods: A community-based survey of 1,464 adults, following the World Health Organization's Stepwise
Approach to Chronic Disease Risk Factor Surveillance, was conducted to estimate the prevalence of hypertension,
awareness, treatment and control in Dande, Northern Angola. Using a demographic surveillance system database,
a representative sample of subjects, stratified by sex and age (18–40 and 41–64 years old), was selected.
Results: Prevalence of hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg
and/or hypertensive therapy) was of 23% (95% CI: 21% to 25.2%). A follow-up consultation confirmed the hypertensive
status in 82% of the subjects who had a second measurement on average 23 days after the first. Amongst hypertensive
individuals, 21.6% (95% CI: 17.0% to 26.9%) were aware of their status. Only 13.9% (95% CI: 5.9% to 29.1%) of the
subjects aware of their condition were under pharmacological treatment, of which approximately one-third were
controlled. Older age, lower level of education, higher body mass index and abdominal obesity were found to be
significantly (p<0.01) associated with hypertension.
Conclusions: Our survey is the first to provide insightful data on hypertension prevalence in Angola. There is an urgent
need for strategies to improve prevention, diagnosis and access to adequate treatment in this country, where a
massive economic growth and consequent potential impact on lifestyle risk factors could lead to an increase in the
prevalence of hypertension and cardiovascular disease.
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In 2008, 17 million deaths occurred worldwide from car-
diovascular diseases (CVDs), of which 80% occurred in
middle and low-income countries [1]. Accounting for more
than 7 million lives lost annually and for 57 million
disability-adjusted life years, arterial hypertension is not
only a major risk factor for CVDs, but also recognized as
the number one single risk factor for death worldwide [2].
The majority of hypertensive individuals lives in developing* Correspondence: jvpires@gmail.com; susana.nery@cisacaxito.org
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reproduction in any medium, provided the orregions, with recent estimates pointing to 75 million suf-
fering from this condition in Sub-Saharan Africa (SSA),
and a projected 125.5 million people affected by 2025 [3].
It is acknowledged, however, that limitations regarding
the availability of data [1,4-6] surround predictive models
such as those proposed by Twagirumuzika et al. [3]. The
same authors stress the importance of using reproducible
methodologies such as the World Health Organization's
Stepwise Approach to Chronic Disease Risk Factor Sur-
veillance (STEPS), in order to produce representative and
accurate data [3,7]. When combined with Demographic
Surveillance Systems (DSSs), this approach has beend. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that can be used in guiding control and prevention of
non-communicable diseases' (NCDs), as in this context,
its longitudinal capability can detect the dynamics of
NCDs and associated factors at the population level [8].
Located in southern Africa, Angola lacks national dis-
ease surveillance data on NCDs, more specifically on those
associated with CVDs [1,9]. Despite having endured a 27-
year conflict period that ended in 2002, Angola has been
repeatedly ranked among the 3 fastest-growing economies
in the World [10]. Given this economic growth and conse-
quent impact on risk factors for CVDs such as hyperten-
sion and obesity, hypertension is likely to become an
increasingly important public health problem in Angola.
In 2007 the CISA project (Centre for Health Research
in Angola, translated) was established as a result of a part-
nership between the Angolan and Portuguese Govern-
ments and the Calouste Gulbenkian Foundation. CISA’s
Demographic Surveillance System (DSS) monitors over
60,000 people, providing reliable demographic information
and facilitating the implementation of epidemiological
studies [11,12].
The aim of this study was to estimate the prevalence,
awareness, management and control of hypertension
and associated factors in an adult population of Angola
through collection of baseline data utilizing the WHO
STEPS' approach and our DSS as a platform. The public
health implications of our findings are discussed in light
of the current economic boom in Angola.
Methods
Study site and design
This community-based survey was conducted in Bengo
Province, Northern Angola in CISA's DSS study area,
which includes three communes (Caxito, Mabubas and
Úcua) of the Dande municipality. Located 60 km north of
Luanda, this area covers a population of 60,000 people,
spread across 4,700 km2 [11,12].
Following the WHO STEPS methodology [7], a repre-
sentative sex- and age (18–40 and 41–64 years) stratified
random sample was drawn from the DSS adult population
database, which comprises 29,614 uniquely identified indi-
viduals aged 18–64 years old. Due to logistic constraints,
probability proportionate to size sampling was used to
choose 35 (out of 69) hamlets in the study area from
which eligible adults could be selected. Fieldwork was con-
ducted during a 12-week period, between October and
December 2011, allowing for the recruitment of 1,464 of
the selected subjects.
Measurement of potential risk factors for hypertension
Information on sociodemographic characteristics and be-
havioural risk factors (i.e. alcohol and tobacco) was gath-
ered using a questionnaire adapted from the WHO’sSTEPS manual (version 2.1) [7], which was translated to
Portuguese (official language) and Quimbundo (a national
language), pre-tested and piloted before data collection.
Frequent alcohol drinkers were defined as subjects that
would consume alcohol 3 or more days per week and
tobacco users were defined as subjects currently smoking
tobacco on a daily basis. The questionnaire was expanded
to include questions regarding hypertension related
awareness (“ever measured blood pressure”, if yes, “ever
told to be hypertensive”) and pharmacological or non-
pharmacological management of hypertension (advices
on diet change, weight loss, exercise or smoking). Place
of residence (urban versus rural) was classified according
to the definition provided by the National Institute of
Statistics [13]. Information on level of education was
obtained from the DSS database and categorized per
number of years of schooling completed: none; one to
four; five to eight and nine or more.
Assessment of hypertension prevalence, awareness,
treatment, control and follow-up
The following physical measurements were taken using
standardized and internationally validated instruments:
blood pressure, weight, height, waist and hip circumfer-
ences [14]. Blood pressure was measured using Omron
M6 automatic sphygmomanometer (HEM-7211-E8 (V))
as recommended [15]. Three readings were taken after a
15-minute rest, three minutes apart. Measurements were
performed with the participant seated, on the right arm
and using the appropriate cuff size (22x32 cm or 32x42
cm). For data analysis, the average of the last two readings
was used, as postulated by WHO [7]. Hypertension was
defined as having a systolic blood pressure (SBP) of
≥140 mmHg and/or diastolic blood pressure (DBP) of
≥90 mmHg and/or reporting use of anti-hypertensive drug
therapy in the previous two weeks. Pre-hypertension was
defined as having SBP levels between 120 and 140 mmHg
or DBP between 80 and 90 mmHg. Awareness was
assessed by asking hypertensive subjects if they had ever
been informed to be hypertensive by a health professional.
Individuals taking anti-hypertensive medication at the
time of survey administration were considered to be con-
trolled if their blood pressure levels were below the
thresholds aforementioned. Anthropometric measure-
ments were taken with participants wearing light clothing
and no shoes. Weight was measured to the nearest 0.1 Kg
using a SECA 803 digital scale. Height was evaluated to
the nearest 0.1 cm, using a SECA 213 portable stadi-
ometer with the individual in the standing position. Waist
and hip circumferences were measured to the nearest
0.1 cm using SECA 203 circumference tape following
standard procedures [14]. Body mass index (BMI) was cal-
culated as weight (Kg) divided by squared height (m2) and
categorized as proposed by WHO [16]: <25 Kg/m2; 25–30
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ratio was calculated to assess abdominal obesity as defined
by WHO: ≥0.9 for men and ≥0.85 for women [17]. Certi-
fied nurses conducted data collection after a one-week
training-period. A follow-up consultation for the partici-
pants classified as hypertensive at the time of data collec-
tion was set up in collaboration with the Bengo General
Hospital. In agreed consultation days, the attending cardi-
ologist, undertook a single blood pressure measurement
after 15 minutes of rest. This measurement was used to
confirm the hypertensive diagnosis, if SBP above 140 mmHg
and/or DBP above 90 mmHg. At the end of the follow-up
period, a survey on perceived barriers to this hypertension
follow-up was conducted among subjects who did not at-
tend their scheduled appointment. A close-ended question-
naire was used for this purpose.
Data management and statistics
Data was double entered into a PostgreSQLW database
system. Analysis was conducted using STATA/SE v.11
software. Sociodemographic characteristics, anthropomet-
ric and physical measurements and hypertension status of
participants were summarized using frequencies (percen-
tages) or means and standard deviations. Taking advantage
of the population sex and age (18–40 versus 41–64 years
of age) strata distribution information available from our
DSS, post stratification survey weights were calculated
and used when estimating prevalence of hypertension and
pre-hypertension, and when conducting all tests of signifi-
cance. Significance level was set at p<0.05 for all hypoth-
esis tests. Contingency tables with Pearson chi-squared
(χ2) tests and pairwise correlations were used to identify
factors associated with hypertension (yes/no, with subjects
who had pre-hypertension grouped with no hypertension)
and blood pressure (mean SBP and mean DSP), respect-
ively. Pertinent variables with a significant χ2 statistic were
used to build a multivariable logistic regression model for
predicting hypertension status in women and men separ-
ately. The final model was evaluated using the area under
the ROC curve and the F-adjusted mean residual goodness-
of-fit test. Estimated prevalences and odds ratios (OR) are
reported with corresponding 95% confidence intervals
(95% CI).
Ethics
The study protocol was approved by the Angolan Ministry
of Health Ethics Committee and written informed consent
was obtained from all the participants before data was
collected.
Results
The study population
There were 1,464 participants in this survey, with the fol-
lowing distribution per strata: 611 women aged 18–40,255 women aged 41–64; 449 men aged 18–40, 149 men
aged 41–64. The mean age of the sample was 33.7 years
old (SD 12.5), with women being slightly older than men
on average (34.3 versus 32.7 years). The majority of the
population was estimated to be living in an urban setting
(87.9%; 95% CI: 86.1% to 89.4%) (Table 1). Just over one
fifth never attended school and 17.9% (95% CI: 16.1% to
20.0%) had a high-school or higher level of education. Ap-
proximately half of the population drank alcohol fre-
quently, with a higher proportion of frequent drinkers
among men (58.8%; 95% CI: 54.9% to 62.7%) than among
women (38.2%; 95% CI: 35.0% to 41.5%). Overall just over
10% of the population had active smoking habits, this per-
centage being lower in women (4.3%; 95% CI: 3.2% to
5.9%) compared to men (18.3%; 95% CI: 15.4% to 21.6%).
The proportion of overweight and obese varied across
gender, being lower in men (14.4% (95% CI: 11.8% to
17.5%) and 3.1% (95% CI: 2.0% to 4.9%) respectively) than
in women (24.1 (95% CI: 21.2% to 27.3%) and 10.3% (95%
CI: 8.4% to 12.7%) respectively). Forty percent (95% CI:
37.8% to 42.3%) of the population was estimated to have
abdominal obesity (Table 1).
The estimated mean SBP and DBP for the population
were 129.8 mmHg (95% CI: 128.9 mmHg to 130.7 mmHg)
and 73.2 mmHg (95% CI: 72.6 mmHg to 73.9 mmHg) re-
spectively. Both mean SBP and mean DBP increased with
age, with a mean SBP of 125.4 mmHg (95% CI: 124.5 mmHg
to 126.2 mmHg) and mean DBP of 70.2 mmHg (95% CI:
69.5 mmHg to 70.9 mmHg) in the younger age group com-
pared to a mean SBP of 140.5 mmHg (95% CI: 138.1 mmHg
to 142.8 mmHg) and mean DBP of 80.6 mmHg (95% CI:
79.3 mmHg to 81.9 mmHg) in the older age group. A stee-
per increase of mean SBP (p<0.01) and mean DBP (p=0.03)
with age was observed in women in comparison to men
(Figure 1).
Hypertension prevalence, awareness, treatment, control
and follow-up
The estimated prevalence of pre-hypertension was 44.8%
(95% CI: 42.3% to 47.4%) and of hypertension was 23.0%
(95% CI: 21% to 25.2%). Figure 2 shows the prevalence
of pre-hypertension, hypertension, awareness, treatment
and “ever measured BP” per sex-age strata. Men had a
higher proportion of hypertension (26.4%; 95% CI: 23.1%
to 30.0%) than women (19.8%; 95% CI: 17.5% to 22.3%)
(p<0.01) (Table 2). When looking at specific sex-age
strata, younger women had the lowest prevalence of
hypertension (8.5%; 95% CI: 6.5% to 11.0%) and older
women the highest (45.1%; 95% CI: 39.1% to 51.3%)
(p<0.01). Amongst hypertensive individuals, 21.6% (95%
CI: 17.0% to 26.9%) were aware of their status. This
prevalence of awareness was significantly (p<0.01) higher
in female subjects (27.5%; 95% CI: 20.3% to 36.1%) com-
pared to male subjects (15.3%; 95% CI: 10.5% to 21.7%)
Table 1 Characteristics of the participants
Female (n=866; 59.1%) Male (n=598; 40.9%) All participants (n=1464; 100.0%)
Characteristics % Unweighted % Weighted*
(95% CI)
% Unweighted % Weighted*
(95% CI)
% Unweighted % Weighted*
(95% CI)
Place of residence
Urban 87.2 86.9 (84.6-89.0) 89.3 88.8 (86.1-91.1) 88.0 87.9 (86.1-89.4)
Rural 12.8 13.1 (11.0-15.4) 10.7 11.2 (8.9-13.9) 12.0 12.1 (10.6-13.9)
Education
None 29.0 29.5 (26.7-32.4) 12.2 12.4 (10.0-15.3) 22.1 21.2 (19.3-23-2)
1-4 years 34.1 34.0 (30.9-37.2) 14.6 14.8 (12.2-17.9) 26.1 24.7 (22.6-26.9)
5-8 years 28.4 28.1 (25.3-31.1) 45.0 44.7 (40.8-48.7) 35.2 36.2 (33.8-28.9)
≥9 years 8.6 8.4 (6.8-10.4) 28.3 28.0 (24.6-31.8) 16.6 17.9 (16.1-20.0)
Body Mass Index
<25 65.5 65.4 (62.2-68.5) 82.8 82.5 (79.2-85.3) 73.2 74.4 (72.0-76.6)
25-30 24.7 24.8 (22.0-27.8) 14.2 14.4 (11.8-17.5) 19.7 19.1 (17.1-21.3)
≥30 9.8 10.3 (8.0-12.0) 3.0 3.1 (2.0-4.9) 7.1 6.6 (5.4-8.0)
Waist to hip ratio
<0.85 women/<0.9 men 42.6 42.4 (39.2-45-7) 79.1 78.5 (75.1-81.5) 59.7 60.0 (57.7-62.2)
≥0.85 women/≥0.9 men 57.4 57.6 (54.3-60.8) 20.9 21.5 (18.5-24.9) 40.3 40.0 (37.8-42.3)
Alcohol consumption
<3 d/wk 61.7 61.8 (58.5-65.0) 41.3 41.2 (37.3-45.2) 53.4 51.8 (49.2-54.3)
≥3 d/wk 38.3 38.2 (35.0-41.5) 58.7 58.8 (54.9-62.7) 46.6 48.2 (45.7-50.8)
Tobacco
No 95.8 95.7 (94.1-96.9) 82.1 81.7 (78.4-84.6) 90.2 88.9 (87.1-90.4)
Yes 4.2 4.3 (3.2-5.9) 17.9 18.3 (15.4-21.6) 9.8 11.1 (9.6-12.9)
* post-stratification weights used as described in the methods section.
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compared to the younger age group (15.4%; 95% CI: 10.1%
to 22.8%) (p<0.01) (Table 2). Eighty-three percent of the
participants who where aware of their hypertensive status
reported having received advice on non-pharmacological
management of hypertension, 90% of which were related
to salt intake. However just 13.9% (95% CI: 5.9% to 29.1%)
(n=11) of the subjects aware of their condition were under
pharmacological treatment, of which only 36.4% (n=4)
were controlled. Less than half of the participants (46.3%;
95% CI: 43.8% to 48.8%) had ever seen their blood pres-
sure measured. The proportion was higher in older indivi-
duals, especially amongst women (67.1%; 95% CI: 61.1% to
72.6%) than in younger individuals, especially men (32.2%;
95% CI: 28.0% to 36.7%) (p<0.01).
Just over one fourth (27.6%) of hypertensive subjects
attended the follow-up consultation at the district hospital.
The mean waiting time between field measurements and
follow-up was 22.9 days (SD 10). The older age group had
a significantly (p<0.01) higher proportion of attendants
(34.4%; 95% CI: 27.6% to 41.9%) than the younger (15.3%;
95% CI: 10.3% to 22.2%). 81.7% of follow-up patients had
levels of SBP and/or DBP above the defined cut-offs forhypertension diagnosis, therefore confirming their status.
Younger participants had a lower proportion (64.2%; 95%
CI: 41.9% to 81.7%) of confirmed hypertensive compared
to the older age group (87.9%; 95% CI: 76.2% to 94.2%)
(p=0.03). Figure 3 compares prevalence levels of hyperten-
sion at follow-up to levels at the time of field survey' ad-
ministration by stratum.
Fifty-five participants (23.0%) who did not attend the
follow-up consultation answered the questionnaire on
perceived barriers to attending this appointment. Lack
of time (41.8%), money (40%) and means of transporta-
tion (34.5%), were the three major reasons pointed out
by respondents.Hypertension associated factors
In general, hypertension was strongly associated with
older age (p<0.01) with an OR of 7.2 (95% CI: 4.7 to
10.9; p<0.01) in women and an OR of 1.7 (95% CI: 1.1 to
2.6; p<0.05) in men (Table 3). Younger women had the
lowest hypertension prevalence (8.5%; 95% CI: 6.5% to
11.0%), followed by younger men (21.2%; 95% CI: 17.6%
to 25.2%), older men (40.3%; 95% CI: 32.7% to 48.3%)
Figure 1 Systolic (SBP) and diastolic blood pressure (DBP) values by sex and age.
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(Table 3).
The prevalence of hypertension increased as the level
of education decreased, being 17.9% (95% CI: 13.5 to
23.4) in those with high school or college education, in
contrast to 35.3% (95% CI: 30.3% to 40.6%) in individuals
with no formal education (p<0.01) (Table 2). Looking at
each gender separately, the association between hyper-
tension and having no formal education did not reach
statistical significance at the 0.05 level in either women
(OR: 2.6; 95% CI: 1.0 to 7.2; p=0.06) or men (OR: 1.8;
95% CI: 0.9 to 3.4; p=0.09). Hypertension was found toFemale 18-40
Female 41-64
Male 18-40
Male 41-64
All participants
Note:
The denominator for awareness only included hypertensive individu
The denominator for treatment only included hypertensive individua
Pre-hypertensive
(n=638)
36.5
34.1
59.0
42.3
44.8
0% 20% 40% 60% 80%
p < 0.01
Hypertensive
(n=322)
8.5
45.1
21.2
40.3
23.0
0% 20% 40% 60%
p < 0.01
Figure 2 Prevalence of pre-hypertension, hypertension, awareness tre
sex-age strata.be more common in individuals presenting higher values
of BMI. The estimated prevalence of hypertension was
almost doubled when comparing the non-overweight/
non-obese group (20.1%; 95% CI: 17.8 to 22.7) to the
obese group (38.1%; 95% CI: 29.1 to 48.0) (p<0.01)
(Table 2). This association between hypertension and
obesity was significant in both men (OR: 4.2; 95% CI: 1.4
to 13.0; p<0.05) and women (OR: 2.0; 95% CI: 1.1 to 3.6;
p<0.05) (Table 3). Among abdominally obese subjects,
the estimated prevalence of hypertension was higher
(29.0%; 95% CI: 25.6 to 32.7) than in those non-
abdominally obese (19.0%; 95% CI: 16.5% to 21.8%)als that had their blood pressure measured.
ls that were aware.
Aware
(n=89)
19.2
46.1
11.6
25.0
21.6
0% 20% 40% 60%
p < 0.01
Treated
(n=11)
20.0
11.3
9.1
13.3
13.9
0% 20% 40%
p = 0.86
Ever Measured BP
(n=680)
49.0
67.1
32.2
51.4
46.3
0% 20% 40% 60% 80%
p < 0.01
atment and “ever measured blood pressure (BP)” per
Table 2 Prevalence of hypertension and awareness according to demographic characteristics, BMI, WHR, alcohol
and tobacco use
Associated factor % Hypertensive (95% CI) P-value % Aware (95% CI) P-value
Sex
Female 19.8 (17.5-22.3) 0.002 27.5 (20.3 - 36.1) 0.01
Male 26.4 (23.1-30) 15.3 (10.5 - 21.7)
Age
18-40 14.8 (12.8-17.1) < 0.0001 15.4 (10.1 - 22.8) < 0.0001
41-64 42.9 (38.1-47.8) 36.4 (29.7 - 43.8)
Education
None 35.3 (30.3-40.6) < 0.0001 22.3 (14.9 - 31.9) 0.28
1-4 years 20.8 (17.0-25.3) 15.5 (8.8 - 25.9)
5-8 years 19.9 (16.6-23.6) 27.6 (18.8 - 38.5)
≥9 years 17.9 (13.5-23.4) 17.3 (8.2 - 32.9)
Body Mass Index
<25 20.1 (17.8-22.7) < 0.0001 23.5 (17.5 - 30.7) 0.41
25-30 28.7 (23.8-34.2) 20.3 (12.9 - 30.5)
≥30 38.1 (29.1-48.0) 14.5 (7.1 - 27.3)
Waist to hip ratio
<0.85 women/<0.9 men 19.0 (16.5-21-8) < 0.0001 18.7 (12.8-26.4) 0.26
≥0.85 women/≥0.9 men 29.0 (25.6-32.7) 24.3 (17.9-32.1)
Alcohol consumption
<3 d/wk 19.4 (16.8-22.3) < 0.0001 29.3 (21.5-38.5) 0.007
≥3 d/wk 26.9 (23.7-30.4) 15.6 (10.8-22.0)
Tobacco use
No 21.4 (19.3-23.6) < 0.0001 23.8 (18.7-29.9) 0.009
Yes 35.6 (28.1-43.9) 8.3 (3.4-18.7)
Weighted prevalences shown.
CI: Confidence Interval.
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sion and abdominal obesity was only significant in men
(OR: 2.5; 95% CI: 1.5 to 4.0; p<0.01) (Table 3).
Hypertension prevalence was significantly higher in fre-
quent drinkers (26.9%; 95% CI: 23.7% to 30.4%) compared
to non-frequent drinkers (19.4%; 95% CI: 16.8% to 22.3%)
(p<0.01) and significantly higher in smokers (35.6%; 95%
CI: 28.1% to 43.9%) than in non-smokers (21.4%; 95% CI:
19.3% to 23.6%) (p<0.01) (Table 2). Nevertheless, when
looking at each gender separately the association between
hypertension and alcohol or tobacco use was only margin-
ally significant in men with an OR of 1.4 (95% CI: 0.9 to
2.2; p=0.08) and 1.6 (95% CI: 1.0 to 2.7; p=0.07), respect-
ively (Table 3).
Discussion
In recent years there has been an effort to provide reliable
data regarding hypertension in SSA, predicted to be the
leading risk factor for CVDs and accounting for a high
burden of morbidity and mortality [1]. To our knowledgethis is the first population-based survey to provide
insightful data on hypertension prevalence and associated
factors in Angola.
One fourth of our DSS population was estimated to be
hypertensive and almost half of the individuals presented
SBP and DBP values compatible with pre-hypertension.
These prevalence levels are within the range of reported
values in surveys performed in SSA using the STEPS
methodology, being lower than the 41% reported for
urban Mozambique [18] but higher than the overall 16%
published for Eritrea [19]. Due to the methodological
differences namely in sampling frames, age groups and
measurement techniques used, direct comparisons be-
tween studies are not possible. Nevertheless our esti-
mates are lower than the 29.5% of overall hypertension
found in the U.S. National Health and Nutrition Exam-
ination Survey (NHANES), 2009 to 2010 cycle, [20] and
also lower than sex-specific prevalence rates reported for
Europe (ranging from 29.3% in Western Europe to
45.6% in Northern Europe) [6].
Figure 3 Differences in hypertension prevalence between field-
survey and follow-up consultation.
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area had never had their blood pressure measured by a
healthcare professional and less than one-fourth of the
hypertensive subjects were aware of their condition. This
value of awareness is lower than the 74.0% found in the
U.S, [20] and than the 40.7% in Northern Europe and
the 70.8% in Central and Eastern Europe [6]. When
compared to other studies performed in SSA our results
are higher than the 14,8% found in Mozambique [18]
but lower than the 34% in Ghana [21] where a similar
study has been performed. As in similar studies, the
prevalence of awareness was higher in women, especially
in the older age group. Previous authors [18,22] have
argued that these findings might be due to the privileged
relationship women have with health care facilities be-
cause of maternal and child-care oriented programs [6].
Among hypertensive patients aware of their condition,
less than 15% (n=11) were under pharmacological treat-
ment, of which only four people fulfilled criteria for con-
trol. Due to these low numbers it was not possible to
make a comparison of control across the sex and age
strata. The lack of awareness, treatment and control might
alert for the possibility that, despite being a growing econ-
omy, Angola´s health system may not be currently able to
provide adequate cardiovascular health care [23]. Further-
more, the extremely low percentage of hypertensive under
treatment may highlight the challenge of convincing these
patients to take lifelong medication in order to treat a dis-
ease, which is usually asymptomatic. In fact, since a frequent
reason (41.8%) given by participants for not attending the
follow-up consultation was lack of time, it is likely that the
hypertensive diagnosis was not considered a priority, sug-
gesting little awareness of the consequences of this condi-
tion among our study population. In addition, money and
transportation were also stated as important limitations,
showing that socio-economic constraints might be an im-
portant limitation to health-care seeking behaviours.
The prevalence of hypertension was significantly higher
among women of older age when compared to otherstrata. In fact, the association with older age proved to be
stronger in women than in men (OR of 7.2 versus 1.7;
p<0.01). The estimated prevalence of overweight in our
study was 40%, higher than 11.7% found in Mozambique
[18] for comparable age-sex strata, whereas obesity was
15%, also higher than the 5.2% reported for that same
country and the double of the value reported for Eritrea
[18,19]. Even though obesity was more common among
older women, the association with hypertension was
stronger in men than in women (OR of 4.2 versus 2.0;
p<0.05). In previous studies addressing the relationship of
obesity and hypertension this effect has been seen, but no
clear explanation was provided for these findings [19].
Due to the low absolute numbers of obese hypertensive in
our survey this effect has to be interpreted with caution.
Frequent alcohol consumption (on 3 or more days per
week) was reported by more than half the participants of
our survey. Although methodological differences in meas-
uring alcohol consumption do not allow for direct com-
parisons between studies, our estimates are higher than
the 16.6% previously reported by Damasceno et al. [18]
and than the 18% reported by Mathenge et al. [24]. Alco-
hol use has been recognized as an important risk factor
for overall disease burden in developing countries [2] fur-
ther justifying the need for future work to better describe
this problem in our setting. Another possible limitation of
our work is the lack of data regarding other lifestyle risk
factors such as unhealthy diet and physical inactivity.
Different studies in SSA, have shown that the prevalence
of hypertension is higher amongst groups with a higher
level of education in rural settings, whereas the inverse
occurs in urban environments [18,25]. Our results did not
confirm this hypothesis. Although the prevalence of
hypertension was lowest in the highest educational group,
this association was not significant after adjusting for gen-
der. Future studies addressing this issue are warranted.
A potential limitation of our study resides on the fact
that participants in this survey were mainly from an
urban setting. Future studies targeting rural populations
are needed to allow for valuable comparisons to studies
preformed by others in similar settings [18-22,25].
There is a growing body of evidence showing that hyper-
tension is more prevalent with increasing urbanization,
which has lead to sedentarism, less healthy diets, increased
alcohol consumption and higher body weights [4,6,18,26,27].
Notwithstanding important socio-economic inequalities
still present in the country, Angola's recent massive eco-
nomic growth is having a profound effect on urban set-
tings, which are becoming more populated and wealthier
[10]. In fact, we found a high prevalence of CVDs lifestyle
risk factors, which will most likely have an impact on the
prevalence of hypertension and associated complications.
Our ongoing DSS will allow for future surveys and/or
intervention studies to be performed and further enlighten
Table 3 Hypertension associated factors and corresponding multivariate adjusted odds ratios by gender
Gender Associated factor % Hypertensive (95% CI) Adjusted OR (95% CI)
Women (n=866)
Age 18-40 (n=611) 8.5 (6.5-11.0) -
41-64 (n=255) 45.1 (39.1-51.3) 7.2 (4.7-10.9)‡
Education ≥9 years (n=74) 8.2 (3.8-17.0) -
5-8 years (n=246) 10.4 (7.1-14.9) 1.2 (0.4-3.3)
1-4 years (n=295) 17.3 (13.4-22.0) 1.6 (0.6-4.3)
None (n=251) 35 (29.5-40.9) 2.6 (1.0-7.2)*
Body Mass Index <25 (n=567) 17.4 (14.7-20.6) -
25-30 (n=214) 22.0 (17.0-28.0) 1.3 (0.8-2.0)
≥30 (n=85) 29.9 (21.2-40.5) 2.0 (1.1-3.6)†
Abdominal obesity No (n=369) 15.9 (12.6-19.9) -
Yes (n=497) 22.6 (19.3-26.4) 1.1 (0.7-1.6)
Alcohol use No (n=534) 18.7 (15.8-22.1) -
Yes (n=331) 21.7 (17.7-26.3) 1.4 (0.9-2.1)*
Tobacco use No (n=829) 18.8 (16.5-21.4) -
Yes (n=36) 39.1 (24.7-55.7) 0.9 (0.4-2.0)
Men (n=598)
Age 18-40 (n=449) 21.2 (17.6-25.2) -
41-64 (n=149) 40.3 (32.7-48.3) 1.7 (1.1-2.6)†
Education ≥9 years (n=169) 21.0 (15.5-27.8) -
5-8 years (n=269) 26.2 (21.3-31.7) 1.3 (0.8-2.1)
1-4 years (n=87) 29.4 (20.7-39.8) 1.4 (0.7-2.6)
None (n=73) 36.0 (25.8-47.6) 1.8 (0.9-3.4)*
Body Mass Index <25 (n=495) 22.4 (19.0-26.3) -
25-30 (n=85) 40.7 (30.8-51.4) 1.9 (1.1-3.3)†
≥30 (n=18) 65.7 (41.8-83.6) 4.2 (1.4-13.0)†
Abdominal obesity No (n=473) 20.8 (17.4-24.7) -
Yes (n=125) 46.9 (38.4-55.7) 2.5 (1.5-4.0)‡
Alcohol use No (n=247) 20.5 (15.9-26.0) -
Yes (n=351) 30.5 (26.0-35.5) 1.4 (0.9-2.2)*
Tobacco use No (n=490) 24.6 (21.0-28.6) -
Yes (n=107) 34.7 (26.3-44.2) 1.6 (1.0-2.7)*
Weighted prevalences shown.
*p<.10; †p<.05; ‡p<.01.
95% CI: 95% confidence interval.
OR: odds ratios.
Factor categories with no response from participants may not always equal the total n for a given group.
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http://www.biomedcentral.com/1471-2458/13/90the impact of these behaviors in the prevalence of hyper-
tension and associated CVDs conditions.
Although adequate treatment and follow-up of hyperten-
sive individuals has been shown to prevent CVD, extend
and improve quality of life, hypertension remains inappro-
priately managed worldwide, especially in SSA [4,18,22,28].
In this study, we aimed to encourage treatment and man-
agement of this condition among the group of participants
identified as hypertensive at the time of field data collec-
tion by establishing a follow-up consultation. Just over 80%of the subjects attending this consultation were given a def-
inite hypertension diagnosis, alerting for the fact that the
methodology applied might be overestimating hyperten-
sion prevalence, as suggested by Bovet et al's work in Tan-
zania [29]. Therefore future hypertension surveys should
have this in consideration as a limitation.
A recent survey on malaria, schistosomiasis, geohel-
minths, anemia and malnutrition among children and
women has shown that these endemic conditions are
important public health problems in our setting [12].
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http://www.biomedcentral.com/1471-2458/13/90Our study, therefore confirms the coexistence of non-
communicable diseases with endemic communicable ones
in the same area, alerting for the need of innovative public
health campaigns to approach this complex epidemiological
transition occurring in Angola, in line with previous reports
from other SSA countries [18,24]. In view of this, DSSs are
uniquely positioned to monitor changes over time and thus
characterize socio-economic modifications that go along-
side with the epidemiological transition.
Conclusions
The impact of Angola’s recent fast economic growth on
risk factors for CVD, in particular those associated with
hypertension, needs to be considered. Future studies
assessing additional lifestyle risk factors for hypertension
such as unhealthy diet and physical inactivity are war-
ranted to understand the potential impact that this eco-
nomic boom might have on hypertension prevalence. Data
provided here call for the implementation of public health
policies to promote primary prevention, early detection
and access to effective treatment options for hypertension
in Angola.
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